A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

NCT03691649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma and Ocular Hypertension

Interventions

DRUG: DE-117 Ophthalmic Solution
DRUG: Timolol Maleate Ophthalmic Solution 0.5%

Sponsor

Santen Inc.